Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Evolent Health Inc (EVH)

195 + Investors. Track Smart Money conviction in EVH. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +5
Streak
1Q ▲
Buyers last Q
51%

Smart Money Signals — EVH

Based on 197 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added EVH than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 75% of 3.0Y peak

75% of all-time peak
197 funds currently hold this stock — 75% of the 3.0-year high of 263 funds (reached 2024 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 9% fewer funds vs a year ago

fund count last 6Q
19 fewer hedge funds hold EVH compared to a year ago (-9% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟡

Slight buying edge — 51% buying

105 buying100 selling
Last quarter: 105 funds bought or added vs 100 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-6 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 54 → 39 → 44 → 38. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

59% of holders stayed for 2+ years

■ 59% conviction (2yr+) ■ 21% medium ■ 20% new
116 out of 197 hedge funds have held EVH for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +134% but shares only +1% — price-driven

Value
+134%
Shares
+0%
Last quarter: the total dollar value of institutional holdings rose +134%, but actual share count only changed +1%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~38 new funds/quarter

37 → 54 → 39 → 44 → 38 new funds/Q
New funds entering each quarter: 54 → 39 → 44 → 38. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 67% veterans vs 21% newcomers

■ 67% veterans ■ 11% 1-2yr ■ 21% new
Entry-cohort mix of 203 holders: 137 (67%) are 2+ year veterans, 23 entered 1–2 years ago, and 43 (21%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 48% AUM from top-100 funds

48% from top-100 AUM funds
41 of 196 holders are among the 100 largest funds by AUM, controlling 48% of total institutional value in EVH. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
2.2
out of 10
Low Exit Risk
Exit risk score 2.2/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — EVH

In 2026 Q2, 105 hedge funds were net buyers of EVH (38 opened a new position, 67 added to an existing one), while 100 reduced or exited (67 trimmed, 33 sold completely) — a 51% buyer ratio, indicating a slight buying edge. 48% of total institutional value in EVH is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +5 funds (more new holders than closures). Total institutional holders: 197.

Hedge Fund Ownership: EVH

How many hedge funds hold EVH — quarterly history vs. share price
Quarterly hedge fund ownership of EVH vs. share price

Market Analysis: EVH

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: EVH

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Evolent Health Inc (EVH) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much EVH has moved relative to its sector benchmark (XLV) since the 2026 Q3 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End September 30, 2026 · 45d ago
EVH
+35.2%
XLV
+11.8%

EVH outperformed XLV by +23.4% since September 30, 2026.

Since 13F Filing Date November 14, 2026 · 0d ago
EVH
+0.0%
XLV
+0.0%

Since the filing became public, EVH outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

10 top-rated funds 1 high-conviction
Consensus
4.5
/ 10
breadth
×
Elite
1.8
/ 10
conviction
Hedge Fund Positioning: EVH
2026 Q3 Stats Unlock in 5 days 195 + Investors

Track Smart Money conviction in EVH. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 195 192 1.56%
13F Shares 112M 111M 0.71%
Total Value $603M $258M 133.54%
New Positions 38 44 -6
Increased Positions 64 58 +6
Closed Positions 34 64 -30
Reduced Positions 65 58 +7
Total Calls 4 3 33.33%
Total Puts 3 3 -
PUT/CALL Ratio 0.75 1.0 Neutral

Statistics: EVH

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q3)

195 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in EVH. Verified SEC 13F-HR filings.

QUARTER:
2026 Q3 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 EVH holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Rubicon Founders LLC 13.38% 5,641,123 $19.7M
2 Rock Point Advisors, LLC 1.61% 1,853,136 $6.5M
3 Fore Capital, LLC 0.10% 116,000 $405K
4 Kennedy Capital Management LLC 0.10% 1,525,667 $5.3M
5 Tempus Wealth Planning, LLC 0.07% 100,774 $352K
6 Ironwood Investment Management LLC 0.06% 49,550 $173K
7 Axq Capital, LP 0.03% 69,569 $243K
8 State of Wyoming 0.03% 113,074 $395K
9 WINTON GROUP Ltd 0.02% 133,600 $466K
10 Brighton Jones LLC 0.02% 291,034 $1.0M
11 ERn Financial, LLC 0.02% 29,574 $103K
12 Quantbot Technologies LP 0.02% 120,735 $421K
13 Y-Intercept (Hong Kong) Ltd 0.01% 193,376 $675K
14 Quinn Opportunity Partners LLC 0.01% 74,687 $261K
15 TSA Wealth Managment LLC 0.01% 14,156 $49K
16 Bolton Securities Corporation 0.01% 15,000 $142K
17 Gamco Investors, INC. Et Al 0.01% 241,500 $843K
18 Jefferies Financial Group Inc. 0.01% 306,100 $1.1M
19 Congress Asset Management Co 0.01% 275,158 $960K
20 Capitolis Liquid Global Markets LLC 0.00% 298,100 $1.0M
21 Qube Research & Technologies Ltd 0.00% 1,518,908 $5.3M
22 Advent Capital Management /de/ 0.00% 50,000 $174K
23 Gabelli Funds LLC 0.00% 153,300 $535K
24 Los Angeles Capital Management LLC 0.00% 274,279 $957K
25 Connor, Clark & Lunn Investment Management Ltd. 0.00% 529,527 $1.8M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Evolent Health Inc (EVH)

What does the Smart Money Trend signal show for EVH?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added EVH than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for EVH?

Slight buying edge — 51% buying: Last quarter: 105 funds bought or added vs 100 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for EVH holders?

Elite ownership — 48% AUM from top-100 funds: 41 of 196 holders are among the 100 largest funds by AUM, controlling 48% of total institutional value in EVH. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held EVH?

59% of holders stayed for 2+ years: 116 out of 197 hedge funds have held EVH for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Evolent Health Inc (EVH) following the 2026 Q3 hedge fund 13F filings?

As of today, EVH has moved +0.0% since the 2026 Q3 13F filing date (November 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (September 30, 2026), EVH has gained +35.2% vs +11.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →